You're listening to the PT Pinecast,
where smart people in healthcare come to
make noise.
Here's your host, Jimmy McKay.
All right.
It's a new, I should say new,
it felt new a couple of years ago
when we were talking about it,
but this is a PT specialty that's gaining
momentum.
And it's about time.
It's the newest thing.
It's been around for a while.
While millions of people are living with
or beyond cancer,
far too few know that physical therapy can
be a game changer in their recovery,
in their function,
and in their quality of life.
But today we've got a little CSM preview
like we've been doing that isn't waiting
for the referral.
They're building the case for why every PT
program,
every clinic and every physical therapist
needs to step up and meet the needs
of this population.
From classrooms to clinics to social
feeds, conferences and clinical practice,
these guests today are helping change the
narrative.
So let's welcome Amanda and Scott to the
show.
And Steve,
Steve's here in spirit is what we'll say.
Steve's been on the show before.
Amanda, Scott's been on the show before,
so I'm going to say welcome for the
first time here to you, Amanda.
Thank you.
And you're in the Lone Star State of
Texas.
Real quick,
what's your superhero backstory,
just to give the audience of context about
you and your career?
Okay, so I went to,
as Scott likes to say,
the greatest physical therapy program in
all the land in Ithaca, New York.
It's gorgeous.
I'm very proud.
Oh yeah, it's gorgeous.
Not this time of year.
go over the summer,
especially if you like wineries and
waterfalls.
But so I went there and everybody goes
into PT school,
maybe thinking athletics or some grand big
picture with no inkling of oncology care.
I graduated even in twenty twenty two.
And so that's relatively recently and
still didn't really know much,
especially when I went in.
So then over COVID they did a really
good job of like keeping us engaged.
They did some speaker series of the
different specialties in physical therapy.
So then in enters Scott on zoom does
a great job explaining, you know,
about oncology care.
And I'm like, wow,
that's a really cool niche kind of fills
my little like nerdy void.
And he said, oh,
if anybody wants to come shadow me up
in Connecticut, I'm like, okay,
that's not too far from New Jersey where
I'm from.
So I went to go shadow him at
least twice, uh,
once in a survivorship program and then
once in just a clinic day.
And that was it for me.
I just decided that that's what I wanted
to pursue.
So I worked, um,
in the New York area after college was
like kind of starting more of like their
oncology program there.
They had a really great like breast
program.
but nothing really coming from medical
oncology.
So I was a big advocate for that
there and then moved down to Dallas,
Texas, started working at UT Southwestern,
which has an amazing oncology rehab
program.
We have like a physical medicine
rehabilitation doctor.
So been doing a lot of that here.
power of story scott we've had you on
the show before but i'm smart enough to
know podcasting is like radio just because
you told a story a couple years ago
doesn't mean the same people are listening
right now so how's that number one my
first question is how'd that make you feel
that you jump on just a zoom call
right with ithaca right great program go
bombers uh and then someone that story
lands
That's number one, but number two,
they took a step.
They liked it more.
They took another step.
So first I want you to do this,
talk about that.
And then I want you to tell the
audience who may not have any idea who
you are,
even though you've been on the show
before,
what that story or a quick snapshot of
what that story was.
Yeah.
I do think being a clinician,
being a PT now for a long time,
I do feel that it's my obligation to
give back to the students.
I realized that being an oncology physical
therapist, like Amanda said,
It is kind of a niche thing,
even though there are twenty million
cancer survivors living in the United
States.
So I would argue that it's not necessarily
niche.
But from a programmatic perspective,
when we talk about DPT programs,
it is rarely, if at all, ever covered.
So that was really cool that I mean,
I really, you know,
I give this talk every year to Ithaca
because it's my way of giving back.
And I'll get into that more in a
second.
And I always say, listen, you know,
I'm an open book and I want you
to learn.
You know,
the best thing I can do at this
point in my career is to help bring
somebody else into this realm.
So, you know,
this is my cell phone and this is
my email.
And, you know, I love having students.
They are the future of our profession,
Jimmy.
You know,
so I'm closer to retirement than I am
being a new graduate.
So, yeah,
so when Amanda reached out to me,
she was like, yeah, like,
I'm willing to make a drive, you know,
yeah,
I'm going to have to drive up to
Georgia to Connecticut to hang out with
you.
And, like, awesome.
Also, you know,
to the power of our alumni association,
and I think everywhere we go, Jimmy,
I know that you've been really, you know,
connected with your alumni association as
well, you know, with your PT program.
So I think that...
Right there, you know,
just the power of those of us that
have graduated,
wherever we've graduated from, you know,
to be able to give back, you know,
to our universities is great.
So it was really, you know,
it was really...
it felt really good yeah to have Amanda
reach out to me and I've had other
students do that now too where they say
listen I want to see what it actually
looks like like it's one thing you know
to have the PowerPoint but what exactly do
you actually do with these patients like
and how is it different and when they
come and they've observed me in clinic
they realize that you know it's just PT
right
It's just the extra twenty percent layer
of knowing what the drugs are and knowing
what these side effects are from the drugs
and being able to read that chart and
decipher it and be able to predict what
those adverse effects are going to be.
So that way we can put on our
PT hats and say, oh,
that chemotherapy in particular can cause
peripheral neuropathy.
If that person can't feel their feet
because of neuropathy,
they're a falls risk.
So what do you do?
Falls prevention.
Any PT could do fall prevention.
It's just a matter of understanding why we
have to do fall prevention for that
patient.
And why would persons with cancer and who
have survived cancer,
why is that particularly,
why is that something important to you?
So I was diagnosed with cancer when I
was in PT school.
I was in my last year of PT
school at Ithaca.
And you could say that I didn't really
fit the profile.
I ran cross country and track for my
four years there at Ithaca.
And I never drank, and I never smoked,
and I never did drugs.
I was always the designated driver for all
my friends and all my teammates.
And there was also no family history of
cancer.
And so I never would have expected in
a hundred years that I'd be diagnosed.
But as a twenty two year old going
into his last year of PT school,
that's what happened.
And, you know, again,
the why I feel so strongly about our
program at Ithaca is because my professors
stood by me and my classmates stood by
me and my professors said,
We're going to get you through this.
You are going to graduate with your
cohort.
You've been with your cohort all these
years.
You're not going to go back.
You're not going to stay back a year.
You will graduate with your classmates.
And so that's why I always feel that
this is a small thing that I can
do to give back to my program.
And that talk even kind of morphed over
the years.
you know,
initially I'd go back and I would just
tell my story.
And really it was almost like a PSA
of, Hey, I was and I got cancer.
So start doing yourself exams now.
Um,
And then as I got more and more
into oncology rehab,
then it morphed more into the actual
oncology lecture.
You know, what is oncology rehab?
What do I do?
And why do these patients need care?
In addition to telling my story.
So, yeah, so Amanda,
you and your classmates kind of heard that
version of it, you know,
both the didactic piece of it,
but also the personal piece of it.
So our audience obviously is not public
facing.
It's pretty much internal to the
profession.
How do you answer this when fellow PTs
find out, this is for both of you,
hey,
this is the type of patients that you
work with.
How do you answer the question,
why do people with cancer need PT?
Why are so few getting it?
I mean, even Amanda,
you said in the middle of PT school,
this wasn't something you went into and
expected to be there,
but once the rationale was there,
I don't think you could shout this enough
just because people like you understand
this deeply.
Why?
What is the answer to that?
Why do people with cancer need PT and
why are so few people getting?
I think that I mean,
I get this question a lot,
usually not so much like from physical
therapists, but like, obviously, yes,
mostly from people like that are not in
health care, be like,
what do you do with cancer?
And I'm like,
everything they need so much.
But from my peers, it's more like, well,
OK, you know about the human body,
obviously,
and the movement systems and everything.
Let's talk about what cancer treatment
does to the human body.
And I explained these things are so
important.
These things save the patient's life.
And previous,
and Scott can attest to this because he
was a part of it as it was
growing.
But previously it was like, oh, no,
like leave these patients alone,
let them rest, let them recover.
OK, well,
now we have so many cancer survivors
because of all these amazing treatments
and they need to get back to doing
things that they were doing before,
whether that's child care,
whether that's their job,
whether that's caring for aging parents.
So what are things that we can do
that help them decrease the effect of
neuropathy,
decrease cancer-related fatigue, decrease,
you know, help people sleep better?
If you're not sleeping well because of,
you know,
like radiation fibrosis to your shoulder
or shoulder pain and scapular dyskinesis,
how can we help this person sleep better
so they can function better during their
daily life?
With neuropathy,
how can we help to decrease their
neuropathy so that they can sleep better,
so they can walk better?
to decrease the risk of falls.
I'm also studying for the specialty exam
right now and just going through the
textbook,
it says something and don't quote me,
numbers are not my strong suit,
but something like forty percent of men
that take androgen deprivation therapy for
prostate cancer will have a fall and a
fracture within the first few years of
taking that.
So we know what these patients are going
to go through because we know the side
effects of the treatment.
So how can we help them during and
after?
or even getting prepared for it.
Sure.
Yeah.
And to kind of answer the second half
of that question, Jimmy, I think the,
you know,
I think there's still a lot of
misconceptions, you know, probably about,
you know, or with our oncology colleagues,
first of all, you know, again,
if somebody has been practicing for thirty
years, thirty years ago,
that's what the evidence said.
Let these patients rest.
Don't let them do anything.
They need to conserve their energy while
they're going through treatment.
So that's what they got in medical school,
oh, thirty years ago.
And so that's probably what their mindset
still is today.
I'm noticing that I'm getting more and
more.
Most of my referrals are coming from
younger oncologists because they're
getting it more in in med school.
And and again, we have the evidence now
In twenty twenty six,
we have all this evidence that shows the
benefit of exercise.
And so now I think the oncologists are
starting to come up with that.
But we're going to have a whole other
conversation about, you know,
we need to make this easier.
Right.
Like, Jimmy,
we've talked about this before.
You talk about this all the time, Jimmy,
the easy button, you know,
the target like, you know,
or Staples easy button.
We need to make it easier for these
oncologists.
and these oncology nurses to get these
patients to us.
They are dealing with so much.
Exercise and rehab is not the first thing
that's on their minds.
And so we need to be able to
build,
if you're in a big academic institution,
like use Epic to our advantage,
like build it into the order set to
make it easier for them to make that
referral.
They just have to hit the button.
rather than fill out all the referral
stuff.
That's where a lot of it gets lost,
honestly.
You've said before that oncology,
physical therapy,
landscape is constantly changing.
What's new
What's new that PTs need to know?
Maybe something that even if they thought
they were on the cutting edge a year
or two ago,
what's something that's a big disruptor
that maybe PTs still,
even if they're ahead of the curve
normally, that they don't know?
Yeah, well, two things there, Jimmy.
First of all,
last year in twenty twenty five in the
New England Journal of Medicine,
kind of what I would consider the holy
grail that we've been searching for for
all of these years.
The challenge trial was published and it
was this huge multicenter study had almost
nine hundred patients with stage two or
stage three colorectal cancer.
And the intervention group
exercise and they had supervised exercise
programs and one of the big things too
about this this trial was that these
patients could do cardio they had to do
forty five minutes of cardio three or four
times a week but they got to choose
the kind of cardio that they wanted to
do so it could have been walking it
could have been hiking it could have been
biking gonna be kayaking
And so they had these checkpoints with
their physiotherapists and exercise
physiologists twice a month for one year.
And then they can continue to still have
touch points once a month for an
additional two years beyond that.
So three years total,
they had somebody checking on them to
making sure they were adhering to exercise
and rehab.
And the researchers found that
Those that exercise decrease the risk of
recurrence of the cancer of colorectal
cancer by twenty eight percent and
decrease the risk of death by thirty seven
percent.
I'm a huge fan of not dying.
So that sounds good.
Right, right there.
Just by exercising,
you decrease your risk of death by one
third.
And that's just the exercise piece of it,
right?
But those patients were monitored.
They had accountability partners.
They also got to choose that type of
exercise.
And then the kicker out of this study,
out of all this great data,
was that when they did an even bigger
analysis and they put exercise up against
chemo,
a very particular chemotherapy drug,
oxaloplatin, they found that exercise,
the patients who exercise,
it was more effective than the
chemotherapy was.
So that's it.
We have the proof that exercise and rehab
can be better than chemo.
improving overall survival for our
patients so that's one big thing that just
came out less than twelve months ago the
other thing and this is kind of you
know alluding to the the talk that amanda
steve and i are going to do at
csm is the the increase in availability
and the development of immunotherapy
Immunotherapy is different than
chemotherapy.
Immunotherapy is more targeted therapy to
try to turn the immune system on to
try to identify the cancer cells and go
after them.
And again,
new data that just came out in January
of twenty six.
The American Cancer Society always
releases updated stats every year.
for the first time,
the overall cancer survival rate,
if we put all the cancers together,
has finally eclipsed seventy percent.
So that's a big deal, right?
That is a big deal because it was
not that twenty, thirty years ago.
And we specifically saw an increase in
survival in some of the harder
cancers that are out there, like melanoma,
that survival rate almost doubled.
The survival rate of patients with liver
cancer almost tripled.
And you could probably say that
immunotherapy had a big role in that
because immunotherapy was not readily
available and readily used,
in the treatment of a lot of these
types of cancer.
And now they are.
And so we're seeing an improvement in
overall survival by adding immunotherapy
to some of the traditional treatments such
as chemotherapy and radiation therapy.
So we know better,
it's just time to make sure we do
better, right?
We've been yelling for research left and
right, now we have it,
now it's time to execute.
Well,
this brings us to your talk at CSM,
doing a lot of these sort of hype
videos, which I think is good.
If you're gonna huck yourself all the way
out to LA,
make sure you understand what's on the
menu,
because I wouldn't want you to miss it.
So Thursday the twelfth,
ten thirty to noon,
nice in the middle of the day,
not too early, not too late, smart.
Um, I like the title.
I don't know if I'm saying it right.
Pronounce it for me.
Sibs, nibs, and mabs.
Oh my.
And identifying opportunities in
immunotherapy rehabilitation.
I gotta be honest, sibs, nibs, and mabs.
I don't know what they are.
Help me out here.
Yeah,
so I think that that's the whole point.
The sibs, mibs, and mabs,
that is the tail end of a lot
of these drugs.
And again, as a student,
as a new clinician,
even a seasoned clinician,
but you're getting into oncology rehab,
or you're working in a sports rehab
center, and you have this patient come in,
and you look at their chart,
and you see these things.
You're like, what?
and God's green earth are these drugs.
And so that's why we wanted to demystify
that.
We wanted to talk about what is
immunotherapy and the effects of
immunotherapy on the body.
And then what we can do as PTs
to make sure that we're keeping our
patients healthy
and keeping them moving and potentially
even helping to help enhance the effects
of immunotherapy as they're trying to work
towards getting rid of the cancer.
Amanda,
what do you hope people who walk out
of your talk are able to do?
What is the goal?
What should they look like?
What should they feel empowered to do?
What's the change happen in ninety minutes
with you guys in L.A.? ?
Yes.
So I,
something that I really want to emphasize
is that even though like the title of
our presentation,
not that it seems daunting,
I think I love Scott's, uh, you know,
idea of bringing in lions, tigers,
and bears.
Um,
but it's not just for seasoned oncology
PTs.
Um,
I think that's a lot of the audience
that we're going to capture.
Um, but.
I want anybody to be able to come
to our presentation and know what are the
possible side effects that they should be
looking for,
for patients that are receiving
immunotherapy,
because it could be somebody that's coming
to you in an ortho clinic for a
knee pain.
It might not be somebody that's going to
a specialized cancer clinician.
They could have either be on immunotherapy
because people are on it for longer
periods of time,
or they have
something big like a CAR T cell therapy.
And we'll get into that in our
presentation,
but it might not be somebody that looks
super ill that needs like specialized
cancer care, or just in your community,
you might not have a specialized oncology
clinician.
So it could be somebody going to any
office for any problem that may have a
history of immunotherapy or may be
currently on it.
So a big thing in our presentation is
what are these side effects?
How do they impact the human movement
system?
That's Steve's whole thing.
It's how do they impact the human movement
system and what like emergencies are you
looking out for?
Because some of these side effects can be
life threatening,
but some of them are very mild.
So we're going to go over the mild
ones, the life threatening ones,
how to keep an eye out for them
in your practice and how to discuss these
with your patient.
Yeah.
I do want to say thanks to Empower
EMR.
If your clinic's stuck in an EMR that
slows you down,
you shouldn't have that EMR.
Empower gives you speed, clean workflows,
and features PTs actually ask for.
Better notes, faster documentation,
smooth operations.
All wrapped in customer support that
doesn't ghost you.
EmpowerEMR.com.
Got to pay the bills here, guys.
Otherwise,
we don't keep the lights on the podcast.
If someone says,
I feel a little bit unprepared,
Why should they come?
Amanda just sort of touched on it.
Is this going to be too over someone's
head or is this pretty available and
accessible?
Like we want those advanced courses,
right?
Just who's this right for?
Who should walk in and sit down?
Yeah.
And as Amanda,
as you were just alluding to,
I think any student and any clinician,
whether they're an oncology specialist or
not,
they should walk in because we hope to
be able to answer those questions so that
anybody who walks in then walks out nine
minutes later and says, oh, okay.
You know, these immunotherapies,
these sims, mibs and mabs,
they're not that scary.
Right.
Because, you know, Amanda,
you just said it like not every clinician
is an oncology clinician.
But again,
with twenty million cancer survivors
living in the country.
This patient could walk into your
traditional mom and pop outpatient sports
clinic in East Tumbleweed, Kansas.
But you have to be prepared for that.
And so we want all clinicians and we
want students,
because I guarantee that's not like we
talked about earlier.
A lot of this is not being covered
in DPT programs.
I would love students to show up to
this so that that way they feel empowered
when they go out on their clinicals.
They could be the ones that are teaching
their CIs what this is.
I like myth busting.
I like correcting at least.
So this is for both of you.
You each get to pick maybe one.
What's a myth about either oncology,
physical therapy, or immunotherapy?
What's one myth?
that you find yourself sort of saying,
well, yeah, okay, yes,
but maybe they're not completely off,
but maybe it's a couple degree course
correction.
I'll give you each an opportunity to
correct one myth or update or drop a
well actually about oncology PT that other
clinicians need to stop missing the mark
on.
Well,
I think one of the things that I
would consider here,
and maybe we're going to get into it
in our talk specifically,
is that immunotherapy is easier than chemo
because it's not chemo.
Right.
Like we all know we have a pretty
good understanding,
even if you're not an oncology PT,
like if you've had a loved one go
through cancer treatment,
like you're kind of used to seeing,
you know,
kind of the telltale signs of what chemo
is, you know,
the hair loss and the nausea and the
vomiting and the fatigue and all that.
And so you look at immunotherapy and you
say, well,
that immunotherapy is not chemotherapy.
Right.
It's not designed to kill all these all
the cells at different points of their
development.
so there's no side effects so it's got
to be good for you but amanda you
were talking about this that there are
mild side adverse effects and there are
some pretty significant side effects from
immunotherapy and as clinicians we might
be the ones who see that for the
first time in these patients and we have
to know what that is recognize it then
be empowered
And to run that up the chain to
the oncologist and say, hey,
I saw Mary Jane in clinic today and
this is how she presented and I know
that she's on, you know, her luzumab.
So I think you need to reach out
to her and get her in clinic and
do a full, you know,
full workup of her.
So I think that's one of the myths
that specifically for our our talk at CSM
to try to bust that myth that just
because it's not chemo,
that it's a breeze.
All right, Amanda, you got to follow that.
What's the thing that you that you know,
what's the what's the rock in your in
your flip flop that you'd like people to
get right once and for all?
Man,
I have so many things in my brain.
I think an important thing that Scott just
brought up about pembrolizumab.
So if you've ever heard of Keytruda in
a commercial,
I'm sure everybody's seen the Keytruda
commercial.
You know what immunotherapy is.
That's pembrolizumab.
So it's much more common than you think.
There are a lot of these drugs out,
even though they're relatively new,
they're being used a lot, like Scott said,
and they are responsible for some of the
increase in cancer survivors.
So there's that.
Jimmy, you do know an immunotherapy, but,
um,
I think a rock in my shoe is
that number one, cancer rehab is sad.
Right.
So a lot of like, man, like,
how do you do that?
Like, you know, I'm like, Oh,
because so many people are surviving.
I mean,
of course I do have some patients that
are stage four more end of life.
It's equally as important for them.
Um,
but I have so many patients that are
surviving and we're doing prehab and it's
not just death and dying,
but I think that the most important thing
that I do want to bring up is
that.
PT belongs in hospice and palliative care.
I think there's a misconception,
especially on an inpatient side,
because I've done that as well.
When you go into the patient's chart,
you see a palliative or a hospice note
and you're like, Oh, defer.
Get that patient off my list.
And, um,
there's another really awesome CSM
presentation about.
You know, palliative care.
Um,
I believe that's Chris Wilson's doing that
one.
Um,
so PT belongs in palliative care and
palliative care is not just when the
patient's dying palliative care,
especially for patients for cancer
patients is often involved from the point
of diagnosis to help with comfort,
but it's not just comfort care and dying.
it's helping them.
And there are ways that physical therapy
should be involved in palliative care.
And just because like,
let's say a patient was, you know,
more end stage, you know,
you weren't expecting them to improve.
You're expecting a decline.
That's an even more important reason why
physical therapy should be involved in
And there are ways to write a plan
of care and write goals for maintenance
therapy where you're not saying, oh,
the patient's not approving,
so I have to discontinue care.
No,
you should be involved to help prevent
decline,
to help prevent increased reliance on
caregivers,
to help them maintain their function and
independence through their end of life,
which is such a huge quality of life
thing.
Yeah, I mean,
I'm so glad you brought that up because,
you know, and right there,
what you were talking about,
like goal writing for that patient who's
at end of life care,
like one of the biggest things that we
could do as rehab professionals in that
setting is caretaker education.
Because if the caretaker, you know,
is trying to do transfers for that
patient, you know,
trying to do bed to commode transfers or
whatever that might be,
and the caregiver throws their back out,
They can't care for their person.
So there is always a role for physical
therapy, especially in that setting.
So Amanda,
thank you so much for saying that.
That's the rock in my shoe.
You each get one shot, one opportunity.
Don't throw it away.
Someone who's listened to this episode to
this point and they're going to get on
a plane or they're on a plane right
now as they're listening and putting
their, their schedule together for CSM.
What's your pitch?
What's your one or two sentences and why
they need to come to your talk?
When they come to our talk,
they are going to feel empowered that they
can treat any patient with a history of
cancer.
We want to be able to demystify not
just immunotherapy specifically and its
treatment in cancer,
but we want to be able to demystify
the whole aspect of oncology care and that
any PT can care for anybody with a
history of cancer.
And they need it.
Amanda, what do you got?
I think that, yes, Scott,
that's it as well.
And we are also going to go over
some cases in our presentation.
So I'm really excited about that.
And it's going to show that there is
a huge opportunity for prehab,
not just in immunotherapy,
but in cancer care.
Because like I mentioned before,
since we know roughly the route that these
patients are going to take with their
treatments,
of course it changes as they monitor the
disease progression,
hopefully lack thereof.
But since we know what they're going to
be going through with the treatments and
the medications that they're prescribed,
how can we prepare these patients for what
they're going to be going through?
which then helps to improve their
function.
It also helps to decrease their anxiety
about the treatments that they're going to
be going through.
And it also helps them move their body
through it.
So I think that highlighting prehab there
and showing the opportunity for
intervention at that point is going to be
so empowering for physical therapists of
any specialty,
but also our oncology colleagues.
Sibs, Mibs, and Mabs, oh my,
demystifying challenges and identifying
opportunities with immunotherapy and
rehabilitation.
That is Thursday at CSM,
ten thirty till noon.
And that is in the oncology section.
Last chance for what we call the parting
shot.
This is the parting shot.
One last mic drop moment.
No pressure.
Just your legacy on the line.
pressure whatsoever.
Scott,
we'll let you go first since you've done
this before.
Amanda, give you some time to formulate.
Parting shot is just whatever your mic
drop moment is, your soapbox statements.
What's the last thing you want to leave
with the audience as we wrap up?
I think we've already covered it,
but I would say that use CSM.
I would say my parting shot right now
is use CSM to network.
build your network, talk to people.
It is absolutely a good thing to have
a little bit of imposter syndrome,
but check your imposter syndrome and go
talk to somebody,
go talk to a seasoned clinician,
because I guarantee you,
those of us that are seasoned clinicians,
we want to talk to you.
And again, like we let off,
I'm already like way into my profession
now.
I know that the future of our profession
are students and new grads.
Please come talk to me because you are
going to grow this profession.
And so use CSM as an opportunity to
talk to somebody.
Please come talk to me.
That's Scott's parting shot.
Please come talk to me.
Amanda, what do you got?
You can reiterate a point you did before
or drop something new.
Doesn't matter.
What's your parting shot?
Yes.
So I'm going to piggyback off of what
Scott just said.
And so I am on the APT Oncology
Students New Professional SIG.
And we host a networking session where...
Anybody interested in oncology rehab,
students, new professionals.
We also have some really awesome seasoned
oncology practitioners like Scott that
always pops in.
Chris Wilson typically pops in as well.
So we are planning to have a really
awesome networking session.
It is Friday the thirteenth.
Spooky.
Nine thirty to ten thirty a.m.
You will find that in the oncology section
in the programming on the app.
And we love to have people that are
just kind of intrigued by oncology.
They don't know much about it,
but they want to learn more.
They want to talk to other students,
new professionals,
even seasoned professionals about it and
just,
make the community grow.
So that's what we like to do.
So I hope we need a better name
though for next year.
This is already locked,
but students and new professionals
networking session.
I feel like with AI,
we can come up.
We will, we got to, we,
this needs to be judged.
We got to judge this and we'll do
it for next year.
Hey, thanks for doing what you do.
Coming to a conference is a great
networking experience,
but the amount of work that you guys
put together and put into these things is
usually no small feat.
A ninety minute presentation doesn't just
happen.
So thanks for doing this.
Steve's not here,
but Steve is a great friend of the
show.
So we'll see you guys in in L.A.
and Anaheim in just a couple of weeks.
And thanks for doing this.
Thanks for having us.
This is great.
Yes.
Thanks, Jimmy.
That's it for this one,
but we're just getting warmed up.
Smash follow, send it to a friend,
or crank up the next episode.
Want to go deeper?
Hit us at pgpinecast.com or find us on
YouTube and socials at pgpinecast.
And legally, none of this was advice.
It's for entertainment purposes only.
Bulls**t!
See, Keith?
We read the script.
Happy now?